<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rastoldo G</submitter><funding>the Ministère de l’Enseignement Supérieur et de la Recherche and CNRS, Programme Investissements d’Avenir, Initiative d’Excellence d’Aix-Marseille Université</funding><pagination>684</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8869897</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>Unilateral vestibular lesions induce a vestibular syndrome, which recovers over time due to vestibular compensation. The therapeutic effect of L-Thyroxine (L-T4) on vestibular compensation was investigated by behavioral testing and immunohistochemical analysis in a rat model of unilateral vestibular neurectomy (UVN). We demonstrated that a short-term L-T4 treatment reduced the vestibular syndrome and significantly promoted vestibular compensation. Thyroid hormone receptors (TRα and TRβ) and type II iodothyronine deiodinase (DIO2) were present in the vestibular nuclei (VN), supporting a local action of L-T4. We confirmed the T4-induced metabolic effects by demonstrating an increase in the number of cytochrome oxidase-labeled neurons in the VN three days after the lesion. L-T4 treatment modu</pubmed_abstract><journal>Cells</journal><pubmed_title>L-Thyroxine Improves Vestibular Compensation in a Rat Model of Acute Peripheral Vestibulopathy: Cellular and Behavioral Aspects.</pubmed_title><pmcid>PMC8869897</pmcid><funding_grant_id>AMX-19-IET-004 and ANR-17-EURE-0029</funding_grant_id><pubmed_authors>Caron P</pubmed_authors><pubmed_authors>Pericat D</pubmed_authors><pubmed_authors>El-Ahmadi A</pubmed_authors><pubmed_authors>Fraysse ME</pubmed_authors><pubmed_authors>Rastoldo G</pubmed_authors><pubmed_authors>Tonetto A</pubmed_authors><pubmed_authors>Marouane E</pubmed_authors><pubmed_authors>Lapotre A</pubmed_authors><pubmed_authors>Tighilet B</pubmed_authors><pubmed_authors>Lopez-Juarez A</pubmed_authors><pubmed_authors>Chabbert C</pubmed_authors><pubmed_authors>Zwergal A</pubmed_authors><pubmed_authors>Watabe I</pubmed_authors><pubmed_authors>El-Mahmoudi N</pubmed_authors></additional><is_claimable>false</is_claimable><name>L-Thyroxine Improves Vestibular Compensation in a Rat Model of Acute Peripheral Vestibulopathy: Cellular and Behavioral Aspects.</name><description>Unilateral vestibular lesions induce a vestibular syndrome, which recovers over time due to vestibular compensation. The therapeutic effect of L-Thyroxine (L-T4) on vestibular compensation was investigated by behavioral testing and immunohistochemical analysis in a rat model of unilateral vestibular neurectomy (UVN). We demonstrated that a short-term L-T4 treatment reduced the vestibular syndrome and significantly promoted vestibular compensation. Thyroid hormone receptors (TRα and TRβ) and type II iodothyronine deiodinase (DIO2) were present in the vestibular nuclei (VN), supporting a local action of L-T4. We confirmed the T4-induced metabolic effects by demonstrating an increase in the number of cytochrome oxidase-labeled neurons in the VN three days after the lesion. L-T4 treatment modu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-22T19:14:29.023Z</modification><creation>2024-11-12T16:33:29.05Z</creation></dates><accession>S-EPMC8869897</accession><cross_references><pubmed>35203333</pubmed><doi>10.3390/cells11040684</doi></cross_references></HashMap>